Mazdutide Research Peptide UK
Why can’t I order GLP-1 products via the website?
Due to online platform restrictions, GLP-1 compounds cannot be purchased directly through our standard website checkout. All GLP-1 orders are therefore processed manually via WhatsApp, with secure payment arranged through Open Banking. Once confirmed, UK orders are dispatched via Royal Mail Tracked 24, providing a fast and fully tracked delivery service.
Mazdutide Price UK
Our current Mazdutide research range:
Mazdutide 10mg — £90
To order or check current availability, contact Axiom Labs UK via WhatsApp.
Prices and availability may change.
What Is Mazdutide?
Mazdutide (IBI362) is an investigational metabolic research compound with activity at both the GLP-1 (glucagon-like peptide-1) receptor and glucagon receptor.
This makes Mazdutide a dual GLP-1 and glucagon receptor agonist.
Its receptor profile differs from single-receptor compounds such as Semaglutide and from GIP/GLP-1 dual agonists such as Tirzepatide.
The combination of GLP-1 + glucagon receptor activity has become an important area of research into appetite regulation, glucose metabolism, energy expenditure and body-weight regulation.
How Does Mazdutide Work?
Mazdutide combines activity across two distinct metabolic receptor pathways:
GLP-1 + Glucagon
These receptors have different physiological roles, allowing researchers to investigate the effects of activating both pathways within a single molecule.
GLP-1 Receptor Activity
GLP-1 is a naturally occurring incretin hormone involved in several metabolic processes.
GLP-1 receptor signalling has been researched in relation to:
- Glucose-dependent insulin secretion
- Appetite signalling
- Satiety
- Gastric emptying
- Glucose regulation
- Food intake
- Body-weight regulation
Glucagon Receptor Activity
Glucagon is a pancreatic hormone with an important role in metabolic regulation.
Research into glucagon receptor signalling includes its relationship with:
- Glucose metabolism
- Hepatic energy metabolism
- Lipid metabolism
- Energy expenditure
- Substrate utilisation
The combination of glucagon receptor activity with GLP-1 signalling is therefore an important area of modern metabolic research.
Why Is Mazdutide a Dual-Receptor Agonist?
Mazdutide is described as a dual-receptor agonist because it targets:
GLP-1 + Glucagon
This gives it a different receptor profile from several other compounds within metabolic research:
Semaglutide — GLP-1
Tirzepatide — GLP-1 + GIP
Mazdutide — GLP-1 + Glucagon
Retatrutide — GLP-1 + GIP + Glucagon
Cagrilintide — Amylin analogue
This makes Mazdutide particularly interesting when comparing different approaches to single, dual and triple-pathway metabolic research.
Mazdutide Research
Mazdutide has been investigated in clinical research involving obesity, body-weight regulation and metabolic health.
Research has examined areas including:
- Body-weight changes
- Waist circumference
- Appetite and satiety
- Glucose regulation
- Insulin sensitivity
- Lipid metabolism
- Liver-related metabolic markers
- Blood pressure
- Cardiometabolic outcomes
- Safety and tolerability
Its combined receptor profile allows researchers to investigate whether glucagon receptor activity alongside GLP-1 signalling produces different metabolic effects from GLP-1 receptor activation alone.
Mazdutide and Metabolic Research
Modern metabolic research increasingly involves compounds designed to influence multiple biological pathways simultaneously.
Mazdutide represents one approach to this research by combining two receptor mechanisms within a single molecule.
GLP-1 receptor signalling is associated with appetite, satiety and glucose-dependent metabolic responses.
Glucagon receptor signalling has important roles in glucose and energy metabolism.
Research into Mazdutide therefore provides insight into how these two pathways may interact when activated together.
Mazdutide vs Semaglutide
Semaglutide and Mazdutide both involve GLP-1 receptor activity, but their overall receptor profiles differ.
Semaglutide:
GLP-1
Mazdutide:
GLP-1 + Glucagon
Mazdutide therefore adds glucagon receptor agonism alongside GLP-1 receptor activity.
Mazdutide vs Tirzepatide
Both Mazdutide and Tirzepatide are dual-receptor compounds, but they target different secondary receptors.
Tirzepatide:
GLP-1 + GIP
Mazdutide:
GLP-1 + Glucagon
Both share GLP-1 receptor activity, while Tirzepatide additionally targets GIP and Mazdutide additionally targets glucagon.
Mazdutide vs Retatrutide
Mazdutide and Retatrutide share two receptor pathways:
GLP-1 + Glucagon
However, Retatrutide additionally targets the GIP receptor.
Mazdutide:
GLP-1 + Glucagon
Retatrutide:
GLP-1 + GIP + Glucagon
Mazdutide is therefore a dual-receptor agonist, while Retatrutide is a triple-receptor agonist.
Mazdutide vs Cagrilintide
Mazdutide and Cagrilintide investigate substantially different metabolic pathways.
Mazdutide:
GLP-1 + Glucagon receptor agonist
Cagrilintide:
Long-acting amylin analogue
Cagrilintide does not primarily act through GLP-1 or glucagon receptors, making the two compounds mechanistically distinct.
Current Mazdutide Research Status
Mazdutide has undergone substantial clinical development, particularly within metabolic and obesity research.
Research continues to examine its efficacy, safety and broader metabolic effects, including the potential significance of combining GLP-1 and glucagon receptor activity.
Its dual-receptor mechanism makes Mazdutide an important compound within research into next-generation metabolic therapies.
Frequently Asked Questions About Mazdutide
What is Mazdutide?
Mazdutide is a metabolic compound with combined GLP-1 and glucagon receptor agonist activity.
Is Mazdutide a GLP-1?
Mazdutide has GLP-1 receptor activity, but it is not exclusively a GLP-1 receptor agonist. It additionally activates the glucagon receptor.
What receptors does Mazdutide target?
Mazdutide targets both the GLP-1 and glucagon receptors.
How is Mazdutide different from Semaglutide?
Semaglutide primarily targets GLP-1, whereas Mazdutide targets GLP-1 + glucagon.
How is Mazdutide different from Tirzepatide?
Tirzepatide targets GLP-1 + GIP, while Mazdutide targets GLP-1 + glucagon.
How is Mazdutide different from Retatrutide?
Mazdutide targets GLP-1 + glucagon, whereas Retatrutide targets GLP-1 + GIP + glucagon.
What strength of Mazdutide does Axiom Labs UK stock?
Our current research range includes:
Mazdutide 10mg — £90
For current availability, please contact Axiom Labs UK directly via WhatsApp.
Mazdutide Research UK – Axiom Labs
Axiom Labs UK supplies Mazdutide 10mg for legitimate laboratory, analytical and scientific research applications.
Due to online platform restrictions, Mazdutide orders are handled exclusively via WhatsApp and cannot be completed through our standard website checkout.
Mazdutide 10mg — £90
For current availability and research procurement enquiries, please contact Axiom Labs UK via WhatsApp.
Important Research Notice
Mazdutide is supplied by Axiom Labs UK strictly for legitimate laboratory, analytical and scientific research purposes.
It is not supplied as a medicine and is not intended for human consumption or self-administration.
Information provided on this page is for educational and scientific reference purposes only and does not constitute medical advice.